Skip to main content
Fig. 3 | Trials

Fig. 3

From: Therapeutic and pharmaco-biological, dose-ranging multicentre trial to determine the optimal dose of TRAnexamic acid to reduce blood loss in haemorrhagic CESarean delivery (TRACES): study protocol for a randomised, double-blind, placebo-controlled trial

Fig. 3

Inhibition of the natural hyperfibrinolysis by a high dose of tranexamic acid administered at the early stage of postpartum haemorrhage. ††p < 0.05. Panel a (circles) : hemorrhagic non treated group, Panel b (triangles): hemorrhagic TA treated group

Back to article page

Trials

ISSN: 1745-6215